Long-term maintenance treatment of psoriasis: the role of calcipotriol/betamethasone dipropionate aerosol foam in clinical practice

Most patients with psoriasis present with localized mild-to-moderate disease. In this case, the application of topical treatments in the first-line setting is recommended in most cases.Among different topical options, the fixed-dose combination of betamethasone dipropionate (BD) and vitamin D analog...

Full description

Saved in:
Bibliographic Details
Main Authors: Gabriella Fabbrocini, Clara De Simone, Paolo Dapavo, Perigiorgio Malagoli, Alessandro Martella, Piergiacomo Calzavara-Pinton
Format: Article
Language:English
Published: Taylor & Francis Group 2022-07-01
Series:Journal of Dermatological Treatment
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/09546634.2021.1998310
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832095388736159744
author Gabriella Fabbrocini
Clara De Simone
Paolo Dapavo
Perigiorgio Malagoli
Alessandro Martella
Piergiacomo Calzavara-Pinton
author_facet Gabriella Fabbrocini
Clara De Simone
Paolo Dapavo
Perigiorgio Malagoli
Alessandro Martella
Piergiacomo Calzavara-Pinton
author_sort Gabriella Fabbrocini
collection DOAJ
description Most patients with psoriasis present with localized mild-to-moderate disease. In this case, the application of topical treatments in the first-line setting is recommended in most cases.Among different topical options, the fixed-dose combination of betamethasone dipropionate (BD) and vitamin D analogue (Cal) aerosol foam (Enstilar®, Leo Pharma) is approved as first-line topical therapy for the treatment of psoriasis in USA and the EU, due to its high efficacy and its favorable administration scheme.The PSO-LONG was the first trial to report on the long-term efficacy and safety of the Cal/DB foam treatment for the proactive management of psoriasis and now, the indications of Cal/BD foam included its use in the psoriasis maintenance treatment. However, the precise role of this treatment and the potential therapeutic schemes in the long-term management of psoriasis need further clarification.This Position Paper, authored by a group of Italian Expert Dermatologists, critically discusses the long-term management of psoriasis with Cal/BD foam in clinical practice. In particular, the biological rationale in the proactive treatment with Cal/BD foam and current evidence regarding this therapeutic approach are presented, along with its application also in patients with moderate-to-severe disease, difficult-to-treat lesions, or within combination regimens. In addition, strategies to improve adherence to long-term treatment of psoriasis are discussed,
format Article
id doaj-art-6908086882564bafbdfeacb70be30cfe
institution Kabale University
issn 0954-6634
1471-1753
language English
publishDate 2022-07-01
publisher Taylor & Francis Group
record_format Article
series Journal of Dermatological Treatment
spelling doaj-art-6908086882564bafbdfeacb70be30cfe2025-02-05T19:02:55ZengTaylor & Francis GroupJournal of Dermatological Treatment0954-66341471-17532022-07-013352425243210.1080/09546634.2021.1998310Long-term maintenance treatment of psoriasis: the role of calcipotriol/betamethasone dipropionate aerosol foam in clinical practiceGabriella Fabbrocini0Clara De Simone1Paolo Dapavo2Perigiorgio Malagoli3Alessandro Martella4Piergiacomo Calzavara-Pinton5Department of Clinical Medicine and Surgery, Section of Dermatology, Federico II University of Naples, Naples, ItalyDepartment of Dermatology, Catholic University of the Sacred Heart, Policlinico “A. Gemelli", IRCCS, Rome, ItalyASO City of Health and Science, University Dermatological Clinic, Torino, ItalyHead Psocare Unit, IRCCS Policlinico San Donato, Milano, ItalyMyskin Dermatology Practice, Tiggiano, Lecce, ItalyDermatology Department, University of Brescia, ASST Spedali Civili, Brescia, ItalyMost patients with psoriasis present with localized mild-to-moderate disease. In this case, the application of topical treatments in the first-line setting is recommended in most cases.Among different topical options, the fixed-dose combination of betamethasone dipropionate (BD) and vitamin D analogue (Cal) aerosol foam (Enstilar®, Leo Pharma) is approved as first-line topical therapy for the treatment of psoriasis in USA and the EU, due to its high efficacy and its favorable administration scheme.The PSO-LONG was the first trial to report on the long-term efficacy and safety of the Cal/DB foam treatment for the proactive management of psoriasis and now, the indications of Cal/BD foam included its use in the psoriasis maintenance treatment. However, the precise role of this treatment and the potential therapeutic schemes in the long-term management of psoriasis need further clarification.This Position Paper, authored by a group of Italian Expert Dermatologists, critically discusses the long-term management of psoriasis with Cal/BD foam in clinical practice. In particular, the biological rationale in the proactive treatment with Cal/BD foam and current evidence regarding this therapeutic approach are presented, along with its application also in patients with moderate-to-severe disease, difficult-to-treat lesions, or within combination regimens. In addition, strategies to improve adherence to long-term treatment of psoriasis are discussed,https://www.tandfonline.com/doi/10.1080/09546634.2021.1998310Psoriasisproactive managementlong-term therapyCal/BDadherence
spellingShingle Gabriella Fabbrocini
Clara De Simone
Paolo Dapavo
Perigiorgio Malagoli
Alessandro Martella
Piergiacomo Calzavara-Pinton
Long-term maintenance treatment of psoriasis: the role of calcipotriol/betamethasone dipropionate aerosol foam in clinical practice
Journal of Dermatological Treatment
Psoriasis
proactive management
long-term therapy
Cal/BD
adherence
title Long-term maintenance treatment of psoriasis: the role of calcipotriol/betamethasone dipropionate aerosol foam in clinical practice
title_full Long-term maintenance treatment of psoriasis: the role of calcipotriol/betamethasone dipropionate aerosol foam in clinical practice
title_fullStr Long-term maintenance treatment of psoriasis: the role of calcipotriol/betamethasone dipropionate aerosol foam in clinical practice
title_full_unstemmed Long-term maintenance treatment of psoriasis: the role of calcipotriol/betamethasone dipropionate aerosol foam in clinical practice
title_short Long-term maintenance treatment of psoriasis: the role of calcipotriol/betamethasone dipropionate aerosol foam in clinical practice
title_sort long term maintenance treatment of psoriasis the role of calcipotriol betamethasone dipropionate aerosol foam in clinical practice
topic Psoriasis
proactive management
long-term therapy
Cal/BD
adherence
url https://www.tandfonline.com/doi/10.1080/09546634.2021.1998310
work_keys_str_mv AT gabriellafabbrocini longtermmaintenancetreatmentofpsoriasistheroleofcalcipotriolbetamethasonedipropionateaerosolfoaminclinicalpractice
AT claradesimone longtermmaintenancetreatmentofpsoriasistheroleofcalcipotriolbetamethasonedipropionateaerosolfoaminclinicalpractice
AT paolodapavo longtermmaintenancetreatmentofpsoriasistheroleofcalcipotriolbetamethasonedipropionateaerosolfoaminclinicalpractice
AT perigiorgiomalagoli longtermmaintenancetreatmentofpsoriasistheroleofcalcipotriolbetamethasonedipropionateaerosolfoaminclinicalpractice
AT alessandromartella longtermmaintenancetreatmentofpsoriasistheroleofcalcipotriolbetamethasonedipropionateaerosolfoaminclinicalpractice
AT piergiacomocalzavarapinton longtermmaintenancetreatmentofpsoriasistheroleofcalcipotriolbetamethasonedipropionateaerosolfoaminclinicalpractice